Medical Cannabis Long-COVID Trial Authorised
Medicinal cannabis and hemp healthcare company Bod Australia Limited (ASX: BOD) has been given authorisation in the UK to trial a cannabis-based medicine with long-COVID patients.
Medicinal cannabis and hemp healthcare company Bod Australia Limited (ASX: BOD) has been given authorisation in the UK to trial a cannabis-based medicine with long-COVID patients.